Wnt signaling pathway pharmacogenetics in non-small cell lung cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Wnt signaling pathway pharmacogenetics in non-small cell lung cancer

Published:2014-07-01 Issue:6 Volume:14 Page:509-522
ISSN:1470-269X
Container-title:The Pharmacogenomics Journal
language:en
Short-container-title:Pharmacogenomics J

Author:

Stewart D J,Chang D W,Ye Y,Spitz M,Lu C,Shu X,Wampfler J A,Marks R S,Garces Y I,Yang P,Wu X

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,Genetics,Molecular Medicine

Link

http://www.nature.com/articles/tpj201421.pdf

Reference49 articles.

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D . Global cancer statistics. Cancer J Clin 2011; 61: 69–90.

2. Higgins MJ, Ettinger DS . Chemotherapy for lung cancer: the state of the art in 2009. Expert Rev Anticancer Ther 2009; 9: 1365–1378.

3. Stinchcombe TE, Lee CB, Socinski MA . Current approaches to advanced-stage non-small-cell lung cancer: first-line therapy in patients with a good functional status. Clin Lung Cancer 2006; 7 (Suppl 4): S111–S117.

4. Kepka L, Sprawka A, Casas F, Abdel-Wahab S, Agarwal JP, Jeremic B . Combination of radiotherapy and chemotherapy in locally advanced NSCLC. Expert Rev Anticancer Ther 2009; 9: 1389–1403.

5. Fietkau R . Stage-III NSClC: multimodality therapy for inoperable tumours. Lung Cancer 2004; 45 (Suppl 2): S113–S123.

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long noncoding RNA H19: functions and mechanisms in regulating programmed cell death in cancer;Cell Death Discovery;2024-02-14

2. DKK1 Impairs the Tumor Response to αPD‐1 Immunotherapy by Inactivating CD8⁺ T Cells and Recruiting MDSC Cells in HNSC;Advanced Therapeutics;2023-10-22

3. CBX4 deletion promotes tumorigenesis under KrasG12D background by inducing genomic instability;Signal Transduction and Targeted Therapy;2023-09-12

4. METTL3 promotes the malignancy of non-small cell lung cancer by N6-methyladenosine modifying SFRP2;Cancer Gene Therapy;2023-04-27

5. SOX1 Functions as a Tumor Suppressor by Repressing HES1 in Lung Cancer;Cancers;2023-04-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3